Anti-NKG2D/CD314 Antibody (Tesnatilimab)
Catalog No.
F1617
Anti-NKG2D/CD314 Antibody (Tesnatilimab)
Featured Products
Tesnatilimab is a humanAn IgG4 monoclonal antibody that targets the immune-activating receptor NKG2D, with potential immunomodulatory and anti-inflammatory activities. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.9 kDa
Dry ice
2242758-08-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ANTI-NKG2D, JNJ-64304500
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P26718
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human NKG2D His at 2 ug/mL can bind Anti-NKG2D/CD314 Antibody (Tesnatilimab)
NKG2D / CD314
Please avoid freeze-thaw cycles.